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Background: The outcome of kidney allograft transplantation is associated with numerous donor-dependent
and recipient-dependent immunological and non-immunological factors. Studies on genetic factors affecting
the non-immunological aspects, like ageing of the kidney allograft and patient outcome are still lacking. The aim
of this study was the analysis of relative telomere length (RTL; T/S ratio) in the biopsy specimens of the transplanted
kidney allograft and its correlation with the delayed graft function (DGF), acute rejection (AR) and chronic allograft
dysfunction (CAD).
Methods: The study enrolled 119 Caucasian kidney allograft recipients (64 M/55 F, mean age 47.32 ± 14.03;
transplantation performed between 2001 and 2012). Organs were harvested from cadaveric donors (59.8 M/40.2 F,
mean age 45.99 ± 14.62).
Results: There were significant differences in RTL assessed in kidney allograft biopsy specimens collected 3–6
months after transplantation between patients with DGF and without DGF (181.8 ± 82.0 vs. 284.6 ± 149.6; p < 0.05)
and in RTL of kidney allograft biopsy specimens collected 18–60 months after transplantation between patients
with AR and without AR (188.1 ± 162.1 vs. 263.3 ± 134.7; p = 0.047). There were significant differences in RTL
assessed in kidney allograft biopsy specimens collected 12–24 months after transplantation between patients
with CAD and without CAD (168.0 ± 120.0 vs. 282.1 ± 158.4; p = 0.038).
Conclusions: Duration of dialysis before transplantation and PRA influence the kidney allograft ageing. Telomere length
assessed in biopsy specimens collected in the peri-transplant period predicts the long-term kidney allograft function.
Complications of kidney transplantation, like DGF, AR and CAD are linked with the telomere length and thus,
graft ageing.
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Table 1 Clinical characteristics of the study group
Recipients (n) Mean ± SD or %
Mean age [years] 119 47.32 ± 14.03
Sex 119 53.8 M%
BMI [kg/m2] 67 25.75 ± 4.50
AH 115 79.13%
HD before Tx 84 78.6 %
Preemptive Tx 84 4.76%
Mean time of D before Tx [months] 80 28.02 ± 19.65
CIT [hours] 93 17.7 ± 6.65
DGF frequency 119 30.25%
AR frequency 119 28.57%
CAD frequency 119 14.29%
Mortality 119 2.52%
SD – standard deviation, M- males, AH – arterial hypertension, HD - hemodialysis,
Tx – transplantation, D – dialysis, CIT – cold ischemia time, DGF – delayed graft
function, AR – acute rejection, CAD – chronic allograft dysfunction.
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The outcome of kidney allograft transplantation is associ-
ated with numerous donor-dependent and recipient-
dependent immunological and non-immunological factors
[1-3]. Among them, genetic factors are of great import-
ance for restoring and maintaining kidney function and
determining the possibility of acute (AR) and chronic
rejection resulting in chronic allograft dysfunction (CAD)
[4-6]. A series of reports regarding polymorphisms of
genes implicated in the immune response after transplant-
ation have been published [7-9]. However, studies on gen-
etic factors affecting the non-immunological aspects, like
ageing of the kidney allograft and patient outcomes are
still lacking. Hence, there is growing interest in cellular
senescence and an increasing number of attempts to asso-
ciate telomere length of the transplanted organ cells with
its survival [10].
Telomeres are located at the ends of eukaryotic chro-
mosomes and their functional role is protection against
the degradation of chromosomes and the maintenance
of genome integrity and stability. They are comprised
of tandem nucleotides repeats (TTAGGG) [11]. The
protective activity of the telomeres depends on many
factors – proteins linked with their function (TNF
receptor associated factor 1 and 2 – TRAF1, TRAF2,
Ku86), the level of telomerase activity and the telomere
length itself. Telomere shortening of about 50–200 bp
occurs with each cell division in the absence of active
forms of telomerase. When the critical telomere length
is reached, the cell starts the process of apoptosis. If
the cell has the ability to regenerate the telomeres, it
becomes immortal and divides without control. An-
other possibility is that after using the replication po-
tential, the cell may also stay in the G1 phase not
responding to external stimuli, yet retaining metabolic
activity and contributing to the formation of inflamma-
tory process [12].
The association between many types of cancer and
non-cancer diseases (arterial hypertension, cardiovascu-
lar disease) and telomere length, as well as telomerase
activity, has been confirmed [13-15]. Telomere length
was also correlated with the deterioration of kidney
function and ageing of the kidney. Moreover, differences
in telomere length between the renal medulla and the cor-
tex were observed [16,17]. It is considered that chronic re-
jection of a kidney allograft may be associated with the
increased ageing of the transplanted organ. A signifi-
cant loss of telomere length, not related to cell division,
has been observed before the kidney rejection process
[18]. Therefore, the aim of this study was analysis of
the relative telomere length (RTL; T/S ratio) in biopsy
specimens of the transplanted kidney allograft and its
correlation with delayed graft function (DGF), AR and
CAD.Methods
Design: Prospective cohort study.
Setting: Clinical Department of Nephrology, Transplan-
tology and Internal Medicine and Transplant Outpatient
Clinic
Participants
The study enrolled 119 Caucasian kidney allograft recipi-
ents (64 M/55 F, mean age 47.32 ± 14.03; transplantation
performed between 2001 and 2012). Organs were har-
vested from cadaveric donors (59.8 M/40.2 F, mean age
45.99 ± 14.62). The population of recipients was dived into
subgroup A – up to 2 years after transplantation (n = 70),
and subgroup B – more than 2 years after transplantation
(n = 49). The division was necessary to set the inclusion
criteria. Subgroup A included first renal allograft recipi-
ents recruited consecutively immediately after transplant-
ation and after giving their consent to participate in the
study, while subgroup B included the first renal allograft
recipients with a functioning organ, recruited from the
Transplant Outpatient Clinic that delivers ongoing care
for kidney transplant recipients following discharge, after
giving their consent to participate in the study. Exclusion
criteria were: more than 1 renal transplantation, lack of
consent, or organ loss/return to dialysis. Kidney allograft
recipients’ detailed characteristics are presented in Table 1.
The main causes of impaired kidney function before trans-
plantation were glomerulonephritis, type 1 and 2 diabetes
(T1DM and T2DM), arterial hypertension and autosomal
dominant polycystic kidney disease (ADPKD). Arterial
hypertension, post-transplant diabetes (PTDM) and ath-
erosclerosis were the main comorbid conditions.
The following parameters were recorded: the recipient
and donor ages and gender, recipient’s body mass index
Domański et al. BMC Nephrology  (2015) 16:23 Page 3 of 7(BMI), the type of dialysis treatment and its duration before
transplantation, cause of impaired kidney function, residual
diuresis, panel reactive antibodies (PRA), cold ischaemia
time (CIT), date of the transplantation, comorbid condi-
tions, occurrence and type of infection after transplantation.
The frequencies of DGF, AR and CAD were observed. The
diagnosis of DGF was determined as the need for dialysis
during the first 7 days after transplantation. Identification
of AR was confirmed clinically (pain and/or swelling of the
kidney graft, body temperature ≥38°C, elevated serum cre-
atinine ≥25% in the absence of other pathology including
infection, urinary tract obstruction, allograft artery stenosis,
or cyclosporine and tacrolimus toxicity), and by biopsy re-
view. The diagnosis of CAD was based on functional and
morphological (biopsy confirmed) deterioration of a renal
allograft at least 3–6 months after transplantation. Blood
samples were collected for creatinine concentration evalu-
ation during the first 7 days after transplantation, and 1, 3,
6, 12, 18, 24, 30, 36, 48 and 60 months after kidney trans-
plantation. Creatinine concentration assessment was per-
formed using a colorimetric method. Biopsy specimens
were collected for analysis of the RTL and renal patholo-
gist review (Banff working classification criteria were used)
in the peri-transplant period (biopsy ‘0’), 3, 6, 12, 18, 24,
36, 48 and 60 months after transplantation and in the case
of deteriorating renal transplant function. All patients
received standard immunosuppressive protocol with triple
drug therapy including calcineurin inhibitor (tacrolimus),
mycophenolate mofetil or mycophenolate sodium, and ste-
roids. Some individuals in subgroup B received cyclospor-
ine, azathioprine and steroids after transplantation, but
were then converted to tacrolimus and mycophenolate mo-
fetil at least 6 years prior to the study. If necessary, the im-
munosuppressive protocol was modified. Informed consent
was obtained from all patients. The local ethics committee
of the Pomeranian Medical University in Szczecin, Poland,
approved protocol of the study.Relative telomere length analysis
DNA was extracted using a mini column-based DNA
isolation kit (A&A Biotechnology, Gdynia, Poland) and
stored at −20°C. A high concentration genomic DNA
sample was prepared in decimal concentrations to cover
all possible measurements. According to standard proce-
dure, telomere length was assessed using two pairs of
primers, i.e. telomere-specific and a single copy gene-
specific (albumin). The design of primers specific to a dif-
ficult sequence of telomeres is challenging and there are
already numerous protocols for this application [19,20].
We used the primers that had already been shown to work
specifically [19], as we found them to be the most optimal
of all of the primers tested in the context of specificity and
to result in no primer-dimer or non-specific products.The PCR conditions used to amplify the telomere frag-
ment were as follows: Initial denaturation and polymerase
activation (hot start) was performed in 95°C for 10 min
followed by two cycles of 94°C/15 s and 49°C/15 s without
fluorescence acquisition. The signal was detected during
another 40 cycles i.e. 94°C/10 s, 66°C/10 s and 72°C/10 s.
Melting analysis (65-95°C range, 0.2°C resolution) at the
end of the reaction was performed to verify the specificity
of the product and indicated Tm= 81.7. The efficiency of
the reaction was no lower than 97.8%. Importantly, this re-
sult was repeatable for all of the samples that were ana-
lysed (in serial dilutions). After the optimisation of primer
concentration, which was estimated to be 0.5 μM, we se-
lected the optimal magnesium chloride concentration of
2.5 mM. Similarly, reaction conditions used to identify the
optimal annealing temperature, magnesium chloride and
primer concentrations for albumin were as follows: de-
naturation 95°C /10 min – hot start; followed by 45 cycles
94°C/10 s, 61°C/10 s and 72/10 s. The Tm of the product
(analysis performed as above) was 80.7 and the efficiency
was 99.6%. The concentration of primers was 0.5 μM
and magnesium chloride 2.5 mM. The telomere length
was assessed using a qPCR system (Roche, LC 2.0) and
SybrGreen kit (Roche, Manheim, Germany).
Statistical analysis
Since distributions of most quantitative variables were
significantly different from normal distribution (p < 0.05,
Shapiro-Wilk test), we used non-parametric tests. Spear-
man’s rank correlation coefficient was used to analyse
correlations between variables and the Mann–Whitney
U test was used to compare values between groups.
General linear model (GLM) was used for multivariate
linear regression analysis with logarithmically trans-
formed RTL as dependent variable. Associations with a
p-value <0.05 were considered statistically significant.
Calculations were performed with Statistica 10 software.
Results
Since, the sub-group B patients were recruited 2 years and
later after transplantation, the 0–3 and 3–6 months time
ranges regard sub-group A individuals only. Among the
individuals with DGF, AR was observed in 9 and CAD in
6 patients. The number of 25 subjects without DGF
underwent AR and 11 developed CAD in later time
period. The analysis of RTL in kidney allograft biopsy
specimens and different variables like recipients’ and do-
nors’ age, duration of dialysis before transplantation, PRA
and creatinine concentration revealed significant, positive
and negative correlations, which are presented in detail in
Table 2. There was a significant positive association be-
tween the age of recipients and RTL in biopsies performed
6 months after transplantation (p = 0.049). A significant
negative association between the age of donors and RTL
Table 2 Overview of the statistically significant
correlations between different variables and relative
telomere biopsy specimens length
Correlation of the relative
telomere biopsy length
N Rs p value
Recipients’ age & RTL 6 months 12 +0.58 0.049
Donors’ age & RTL 12–24 months 43 −0.36 0.017
Donors’ age & RTL 12–60 months 53 −0.28 0.045
Duration of dialysis before Tx & RTL 24 months 9 −0.74 0.024
Duration of dialysis before Tx & RTL 18–60 months 17 −0.47 0.05
PRA & RTL 6 months 8 −0.73 0.04
Creatinine 12 months & RTL 0 months 17 −0.60 0.01
Creatinine 12–18 months & RTL 0 months 17 −0.61 0.009
Creatinine 18 months & RTL 0–6 months 24 −0.54 0.006
RTL – relative telomere length, BMI – body mass index, Tx – transplantation,
PRA – panel reactive antibodies, p value calculated for Spearman’s rank
correlation coefficient (Rs).
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transplantation was observed (p = 0.017 and p = 0.045 re-
spectively). Negative correlations between the longer dialy-
sis duration before the transplantation and RTL in biopsy
specimens collected 24 and 18–60 months after transplant-
ation were observed (p = 0.024 and p = 0.05, respectively).
There was a significant negative association between PRA
and RTL in biopsies performed 6 months after transplant-
ation (p = 0.04). There were strong associations be-
tween long-term creatinine concentrations (12, 12–18
and 18 months) and RTL in biopsy specimens collected in
the short period after transplantation (p = 0.01, p = 0.009,
p = 0.006, respectively). There were no associations be-
tween CMV infection and RTL in biopsy specimens col-
lected at different time points after transplantation.
There were no differences in RTL assessed in biopsies
performed 0–3, 12–24 and 18–60 months after transplant-
ation between patients with DGF and without DGF. How-
ever, significant differences in RTL assessed in kidney
allograft biopsy specimens collected 3–6 months after
transplantation between patients with DGF and without
DGF were observed (181.8 ± 82.0 vs. 284.6 ± 149.6;
p < 0.05) (Table 3). There were no differences in RTL
assessed in biopsies performed 0–3, 3–6 and 12–24Table 3 Mean values of the RTL in kidney allograft biopsy spec
Biopsy [months] Patients with DGF
Relative telomere length
N Mean ± SD
Biopsy 0-3 15 234.2 ± 108.8
Biopsy 3-6 9 181.8 ± 82.0
Biopsy 12-24 11 199.1 ± 105.8
Biopsy 18-60 9 193.1 ± 105.3
RTL – relative telomere length, DGF- delayed graft function, SD- standard deviationmonths after transplantation between patients with AR
and without AR. However, significant differences were
found in RTL assessed in kidney allograft biopsy speci-
mens collected 18–60 months after transplantation be-
tween patients with AR and without AR (188.1 ± 162.1
vs. 263.3 ± 134.7; p = 0.047) (Table 4). In the case of
sub-group A individuals (up to 2 years after transplant-
ation) 3 of them did not recover the graft function after
AR fully and developed CAD. There were no differ-
ences in RTL assessed in biopsies performed 0–3 and
3–6 months after transplantation between patients with
CAD and without CAD. However, significant differences in
RTL assessed in kidney allograft biopsy specimens col-
lected 12–24 months after transplantation between pa-
tients with CAD and without CAD were observed
(168.0 ± 120.0 vs. 282.1 ± 158.4; p = 0.038). The RTL in
specimens collected 18–60 months after transplantation
was shorter in patients with CAD; however, these differ-
ences were not statistically significant (Table 5). We have
found in the multivariate linear regression analysis ad-
justed for donor’s and recipient’s age (Table 6) that DGF is
an independent factor associated on the border of statistical
significance with shorter RTL 3–6 months after transplant-
ation (p = 0.089). In similar analyses we observed that AR is
an independent factor significantly associated with shorter
RTL 18–60 months after transplantation (p = 0.048) and
CAD is an independent factor significantly associated with
shorter RTL 12–60 months after transplantation (p = 0.02).
Discussion
In the present study, we found that age of the recipient is
positively significantly correlated with RTL and that age of
the donor, duration of the dialysis before the transplant-
ation, PRA and long-term creatinine concentrations are
negatively significantly correlated with RTL in biopsy spec-
imens collected at different time points. Moreover, we ob-
served a significant shortening of the telomere length in
patients with DGF, AR and CAD. In the study of Oetting
et al., telomere length was determined in kidney allograft
recipients and their donors. Significant associations were
found between log-transformed telomere length and donor
age (p = 3.8 × 10−4), as well as recipient age (p = 5.6 × 10−8).
No associations between log-transformed telomere lengthimens collected from patients with DGF and without DGF
Patients without DGF p value
Relative telomere length
N Mean ± SD
47 287.2 ± 146.0 0.25
30 284.6 ± 149.6 <0.05
34 278.8 ± 167.2 0.18
25 246.4 ± 161.4 0.56
, p value calculated with the Mann–Whitney U test.
Table 4 Mean values of the RTL in kidney allograft biopsy specimens collected from patients with AR and without AR
Biopsy [months] Patients with AR Patients without AR p value
Relative telomere length Relative telomere length
N Mean ± SD N Mean ± SD
Biopsy 0-3 10 270.8 ± 151.6 52 275.0 ± 138.0 0.99
Biopsy 3-6 8 253.2 ± 184.4 31 262.9 ± 133.8 0.64
Biopsy 12-24 18 241.7 ± 163.7 27 271.1 ± 154.7 0.44
Biopsy 18-60 14 188.1 ± 162.1 20 263.3 ± 134.7 0.047
RTL – relative telomere length, AR – acute rejection, SD- standard deviation, p value calculated with the Mann–Whitney U test.
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in agreement with our observations (age correlation);
however, the associations reported by Oetting et al. for
telomere length with AR and CAD are contrary to our find-
ings. The differences in the results can be easily explained;
whereas Oetting et al. analysed the telomere length in per-
ipheral blood white blood cells, we examined the telomere
length of kidney allograft biopsy specimens.
The generally observed variations in telomere length
were thought to be related to longevity potential. It was
confirmed that individuals who inherit longer than aver-
age telomere length tend to have increased lifespans.
Because of the strong association between chronological
age and telomere length, its measurement has been pro-
posed as a marker evaluation of biological age for tissues
and organs, including kidney allografts [21-23]. Based on
an observation that chronological donor age is the most
potent predictor of long-term outcome after kidney trans-
plantation, Koppelstaetter et al. hypothesised that an esti-
mate of telomere length and mRNA expression levels of
the cell cycle inhibitors in zero hour biopsies would be of
high predictive value. The authors observed a negative
significant correlation between RTL and donor age. More-
over, they found that RTL was significantly negatively
associated with serum creatinine concentration measured
12 months after transplantation (p = 0.035). These ob-
servations are in strong agreement with our results.
Unfortunately, Koppelstaetter et al. did not analyse the
correlations between RTL and DGF, AR or CAD. They
did however correlate other variables like gender, CIT,
PRA and AR with creatinine concentration 12 monthsTable 5 Mean values of the RTL in kidney allograft biopsy sp
CAD
Biopsy [months] Patients with CAD
Relative telomere length
N Mean ± SD
Biopsy 0-3 5 343.5 ± 79.6
Biopsy 3-6 4 336.5 ± 91.4
Biopsy 12-24 9 168.0 ± 120.0
Biopsy 18-60 10 178.7 ± 132.8
RTL – relative telomere length, CAD – chronic allograft dysfunction, SD- standard deafter transplantation and found no significant asso-
ciations [24].
There has been a lack of studies assessing the telomere
length in regard to immunological complications after
kidney transplantation. A report by Joosten et al. linked
the telomere shortening with CAD in rats. They found a
significant reduction in telomere length in all transplants
and suggested that one of the causes of telomere short-
ening may be ischaemia and reperfusion injury resulting
in the production of reactive oxygen species. More im-
portantly, these authors state that accelerated aging of
the renal allograft is not only associated with the age of
the donor or the recipient, but also with the damage to
the transplanted organ directly affecting the telomere
shortening [18,25]. We made similar observations in our
study. Despite the influence of donor and recipient age on
the RTL, post-transplant complications like DGF, AR and
CAD significantly affected telomere shortening. Moreover,
these effects were ‘time-related’. The frequency of DGF,
which is the result of ischaemia and reperfusion injury,
was significantly associated with RTL in biopsies spe-
cimens collected 3–6 months after transplantation. We
found no such association in regard to specimens col-
lected 0–3 months after transplantation, because some of
the renal allografts had undergone biopsy ‘0’ during CIT,
before reperfusion and thus were not exposed to the
damage yet. Specimens collected 3–6 months after
transplantation were originating from kidneys exposed
to the ischemia-reperfusion injury resulting in RTL de-
crease. Moreover, we can assume that the effect of DGF
on the telomere shortening sustained until 6 monthsecimens collected from patients with CAD and without
Patients without CAD p value
Relative telomere length
N Mean ± SD
57 268.3 ± 141.9 0.15
35 252.3 ± 146.0 0.15
36 282.1 ± 158.4 0.038
24 254.6 ± 152.3 0.16
viation, p value calculated with the Mann–Whitney U test.
Table 6 Multivariate linear regression analysis adjusted
for donor’s and recipient’s age of the independent risk




RTL 3–6 months RTL 12–60 months RTL 18–60 months
p value p value p value
DGF 0.089 * NS NS
AR NS NS 0.048*
CAD NS 0.02 * NS
DGF – delayed graft function, AR – acute rejection, CAD – chronic allograft
nephropathy, RTL – relative telomere length; p values calculated with general
linear model.
*negative association (risk factor associated with lower RTL).
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time period possibly due to normal telomerase activity.
Gingell-Littlejohn et al. correlated the telomere length in
pre-implantation time zero biopsies with renal allograft
function up to 1 year after transplantation. They also
assessed the CDKN2A ageing biomarker expression. The
authors found a significant association between telomere
length shortening and deteriorating eGFR 6 months and
1 year after transplantation; however, they did not correl-
ate telomere length with DGF and AR [26]. We found a
significant association between AR occurrence and telo-
mere shortening in biopsy specimens collected 18–60
months after transplantation. The majority of AR episodes
can be observed during the first post-transplant year and,
in some cases, even later resulting in graft function impair-
ment and fibrosis. The shorter RTL because of AR were
observed in biopsies performed in the long-term period
after transplantation, possibly due to damage related
changes in telomerase activity.Conclusions
It is important to indicate modifiable factors like duration
of dialysis before transplantation and PRA and their influ-
ence on the accelerated ageing of the transplanted organ
in order to improve transplantation outcome. Telomere
length assessed in biopsy specimens collected in the peri-
transplant period predicts the long-term kidney allograft
function. Complications of kidney transplantation, like
DGF, AR and CAD are linked with the telomere length
and thus, graft ageing.
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